Recent Patents on Anti-Cancer Drug Discovery

ISSN: 1574-8928 - Volume 3, 3 Issues, 2008

Upcoming titles of Recent Patents on Anti Cancer Drug Discovery:

Contents


Update on Aurora Kinase Inhibitors in Gynecologic Malignancies
Wei Hu

The role of XRCC4 in carcinogenesis and anticancer drug discovery
Da-Tian Bau

Targeting Heparan Sulfate Proteoglycans in Breast Cancer Treatment
George W. Yip

Peptides homing to tumor vasculature: imaging and therapeutics for cancer
Kaichun Wu

Proteasome Inhibitors Therapeutic Strategies for Cancer
Andrea Urbani

Pregnane X receptor and its potential role in drug resistance in cancer treatment
Daotai Nie

Anti-HER2 treatment and breast cancer: state of the art, recent patents, and new strategies
Anna Sapino

Tyrosine kinases and the Ras-MAPK pathway in bladder cancer as therapeutic targets
Kamal S. Pohar

MicroRNAs
Elizabeth M. Petty

Oncolytic viruses including their history, suggested mechanisms and the current clinical
Benjamin Gesundheit

Small GTPase RhoA and its downstream effector Rho kinases (ROCK)
Yu-Wen Chang

Cetuximab in head and neck cancer
M C Merlano

Drugs that target bone-resorption (mainly bisphosphonates, but also antibodies blocking RANKL) as anti-cancer drugs in bone tumors
Françoise Rédini

Ubiquitin ligase Skp2 as an oncogene in solid cancers and the mechanisms that alter its regulation
Dan Hershko

Drugs targeting histone deacetylase(HDAC), or Epigenetic theraphy
Bin Guo

Potential use of proprotein convertases as new targets in cancer theraphy
Khatib A-Majid

Targeting AKT and angiogenic pathway in treating hepatoceullar carcinoma patient
Thomas Yau

Molecular aspects of gliblastoma invasion
Dorota Goplen

EGF-R monoclonal antibodies in the treatment of colorectal cancer (in particular Panitumumab)
Nick Maisey

A review surrounding the kinase, Bmx
Christopher D. Willey

HPV vaccines
Arrigo fruscalzo

Therapeutic targets in BRAF-MEK-ERK pathway for treatment of malignant melanoma
Pei-Hsin Huang

liposomal anticancer drugs
Jie Ma

ER stress and UPR and their role in cancer Dietary soy protein genistein and its anti-leukemic effect
Matiullah Khan

New drugs in metastatic breast cancer
Parham Khosravi Shahi

Selective targeting of pediatric bone sarcomas by novel proteasome inhibitors
Farasat Zaman

NF-kappaB signaling pathway as a drug target for cancer therapy
Günter Schneider

Targeted therapy (in particular angiogenesis inhibitors in renal cell carcinoma)
Jean-Pascal Machiels

Role of phospholipids and sphingolipids in anticancer therapy

Revlimid
Ray Powles

EGFR targeting in colorectal and lung cancer
Antoine Italiano

Radiochemotherapy in gastric cancer
Gennaro Galizia

Human Genetic and Structural Genomic Variation, DNA chips and Personalized Surgery for Breast Cancer
Dimitrios H Roukos

Drugs targeting HIF1 alpha and/or hypoxia Antagonist binding to orphan nuclear receptors
Sridhar Mani

Insulingrowth factorreceptor targetted therapy in cancer
Madeleine Hewish

The era of target therapy: are we ready for lung cancer
Marina Cazzaniga

Potassium ascorbate with ribose against cellular degeneration
M. Conti

Herbal-based anti-cancer therapeutics a patent review 1991 2005
Manish Gautam

BARD1 oiling the death spokes in cancer cells
Shazib Pervaiz and Irmgard Irminger-Finger

Potassium channels, a new target field for anti-cancer drug design
Antonio Felipe

PARP-Inhibitors, Unheeded Anti-Cancer Chemotherapeutics
Ming Lei

Anticancer effects of glycolys inhibition with 2-deoxyglucose (2 DG) and 2-fluoro-deoxyglucose (2-FDG)
Luis E. Raez

Plant natural products as chemotherapeutic agents
Navindra P. Seeram